Log in
AMEX:EHC

Encompass Health Price Target, Predictions & Analyst Ratings

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume620,391 shs
Average Volume618,344 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Analyst Ratings

Encompass Health (AMEX:EHC) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
14 Wall Street analysts have issued ratings and price targets for Encompass Health in the last 12 months. Their average twelve-month price target is $86.73 The high price target for EHC is $100.00 and the low price target for EHC is $68.00. There are currently 1 sell rating, 1 hold rating and 12 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
EHC Consensus Rating: BuyBuyBuyBuy
EHC Consensus Rating Score: 2.792.772.792.80
EHC Analyst Ratings: 1 Sell Rating(s)
1 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
1 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
1 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
1 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
EHC Consensus Price Target: $86.73$87.86$86.87$85.88
EHC Price Target Upside: N/AN/AN/AN/A

Encompass Health (AMEX:EHC) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Encompass Health (AMEX:EHC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
11/23/2020BarclaysUpgradeEqual Weight ➝ Overweight$96.00
11/2/2020Credit Suisse GroupLower Price TargetOutperform$89.00 ➝ $85.00
11/2/2020Raymond JamesLower Price TargetOutperform$86.00 ➝ $78.00
10/30/2020Deutsche Bank AktiengesellschaftLower Price TargetHold$83.00 ➝ $70.00
7/27/2020Jefferies Financial GroupLower Price TargetBuy$90.00 ➝ $86.00
5/29/2020MizuhoLower Price TargetBuy$90.00 ➝ $87.00
5/1/2020UBS GroupLower Price TargetBuy$96.00 ➝ $90.00
4/20/2020Royal Bank of CanadaReiterated RatingBuy$84.00
4/20/2020BMO Capital MarketsBoost Price TargetOutperform$66.00 ➝ $83.00
3/5/2020Robert W. BairdBoost Price TargetOutperform$85.00 ➝ $100.00
3/5/2020StephensBoost Price TargetOverweight$91.00 ➝ $100.00
2/10/2020Piper SandlerBoost Price Target$77.00 ➝ $89.00
2/10/2020SunTrust BanksBoost Price TargetPositive ➝ Buy$90.00 ➝ $100.00
1/22/2020JMP SecuritiesBoost Price TargetOutperform$85.00
12/11/2019Wells Fargo & CompanyDowngradeMarket Perform ➝ Underperform$68.00
9/6/2019Bank of AmericaUpgradeNeutral ➝ Buy$73.00
8/12/2019Craig HallumReiterated RatingBuy$81.00 ➝ $76.00
7/31/2019Piper Jaffray CompaniesSet Price TargetBuy$77.00
(Data available from 11/28/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 11/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.